Life-threatening bleeding episodes in infants have become significantly more common, with researchers connecting this trend to an increasing number of parents declining the routine vitamin K shot for newborns. The injection, recommended for over six decades, is crucial for preventing a rare but potentially fatal condition known as vitamin K deficiency bleeding (VKDB).
A comprehensive study analyzing electronic health records of 5.2 million babies born between 2017 and 2025 revealed that approximately 4.5% of infants did not receive a documented vitamin K shot. These babies were found to be at a substantially higher risk for bleeding events.
Babies born without the vitamin K injection experienced 288 bleeding events per 10,000 births in their first six months, a stark contrast to the 186 events per 10,000 births among those who received the shot. Even after adjusting for various factors like gestational age and maternal characteristics, infants without the injection had a 47% elevated risk of bleeding.
Increased Risk of Serious Bleeding
The study highlighted a particular concern for bleeding in or around the brain. Infants who did not receive the vitamin K shot showed more than double the risk of intracranial bleeding, with 33 cases per 10,000 births compared to 13 among those who received the injection. Death during the birth hospitalization was also more frequent in infants with a bleeding diagnosis who had not received the vitamin K administration.
Researchers estimate that for every 114 newborns who forgo the shot, there is one additional bleeding event within the first six months of life. The study authors noted that the excess risk among infants without vitamin K was consistent throughout the study period.
Reasons for Declining Uptake
The decline in vitamin K shot administration is occurring amid a broader increase in parental distrust of public health recommendations, a trend that has gained momentum since the COVID-19 pandemic. Healthcare professionals emphasize that the vitamin K shot is not a vaccine but a supplement of a naturally occurring vitamin essential for blood clotting.
Consequences of VKDB
Vitamin K deficiency bleeding can lead to severe internal hemorrhaging, particularly in the brain or gut, and can manifest as unexplained bruising, seizures, or vomiting blood. In severe cases, VKDB can result in permanent brain damage or death. Approximately 20% of infants who develop VKDB die, and about 40% of survivors experience long-term neurological damage. Alarmingly, many infants show no warning signs before bleeding begins.